• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/33

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

33 Cards in this Set

  • Front
  • Back

stages of the cell cycle

G1, S, G2, M



duration of different stages of cell cycle vary in different organisms and at different stages of development

G1 phase

at the end of G1 phase, G1/S and S-phase cyclin-Cdk is activated

S phase

only S-cdk-cyclin is active --> S phase


replication of DNA

G2 phase

at end of G2 and beginning of M, M phase cyclin-Cdk is activated

M phase

mitosis: prophase, metaphase, anaphase, telophase, cytokinesis



mid M phase: cylins and sister chromatid cohesion are degraded

rationale for chromosome condensation and sister chromatid cohesion

separation of chromatids without tangling

mitotic spindle

-aster microtubules radiate out from centrosome in all directions; associate with membrane and pull centrosome away from metaphase plate


-kinetochore microtubles bind the kinetochore on the sister chromatids; are shortened to pull sister chromatids apart


-interpolar microtubles overlap at the metaphase plate, and provide motor protein pushing/sliding force to separate centrosomes


-self organizes: growing and shrinking MTs radiating from centrosome encounter and bind kinetochores; preformed MTs are captured by centrosomal MTs and pulled in

control of cdks

-accumulation of cyclins


-phosphorylation


-Cdk inhibitors (CKIs)


-proteolytic degredation

SCF and APC ubiquitin ligase complexes

-SCF: active at G1/S transition; multiple F-box proteins allow it to target multiple substrates (e.g. G1/S cyclins and cdk inhibitors); most F-box proteins bind to phosphorylated targets, so SCF couples phosphorylation with irreversible degredation


-APC: active at metaphase to degrade M cyclins and proteins that hold sister chromatids together; is activated by M-cdk (turns itself off/provides negative feedback for M-cdk)



these complexes link the phosphorylation of or by cyclin-CDK to their degredation (progress begets further progress, no going back)

biochemical oscillators

-achieved with a delayed negative feedback loop (e.g. the M-cdk's activation of APC, which then ubiquitinizes M-cdk)

overall logic of the cell cycle control system

at each stage the machinery acts to reinforce the current stage, inhibit the preceding stage, and prepare for the next stage

control of cdks by levels of cyclin

cyclin levels are regulated by transcription and degredation; which cyclin is at highest concentration helps determine which cdk-cyclin is active b/c cyclin is essential for active cdk

control of cdks by phosphorylation

cyclin-cdk must have positive phosphorylation (Thr160) to be active, but also must not have negative phosphorylation (Thr14/Thr15)



negative phosphorylation by Myt1 or Wee1


dephosphorylation by Cdc25, which serves as a trigger

control of cdks by cdk inhibitors

CKIs bind and inhibit active site of cdk


two different classes of CKIs inhibit different cdks

control of cdks by proteolytic degredation

-cdk-cylins become ubiquitinized so are degrades by the proteasome


-two ubiquitin ligase complexes (SCF and APC) regulate the cell cycle by targeting proteins for destuction



-protein degradation is great because it is an irreversible control, thus it ensures that once a particular stage of the cell cycle is attained, it cannot easily go back

bistable switch

-simple regulation by interaction of two components leads to a graded response (as ligand increases, so too does activated protein)


-cell cycle needs a switch


-established by having multiple positive feedback loops (i.e. activated cyclin-cdk provides additional activation of its activator and inhibition of its inhibitor)

role of START

-key checkpoint (G1 checkpoint)


-past START there's no going back, you have to replicate the genome and divide


-ask are mitogens present? is the cell big enough? is DNA intact?


-might be part of the genetic program to not go through START after differentiation

mechanism of START

-mitogen binds mitogen receptor


-receptor activates G1-cdk


-G1-cdk phosphorylates Rb (inhibiting it)


-inactive Rb releases E2F (activating)


-active E2F promotes transcription of G1/S genes

mechanisms of activation of G1-cdks

-ras pathway


-PI-3 kinase/Atk pathway



-both stimulated by mitogens

RAS pathway

-leads to transcription of G1 and G1/S genes


-activation of Ras by mitogens activates a kinase cascade leading to activation of MAPK (mitogen activated protein kinase)


-MAPK phosphorylates nuclear factors that promote transcription of immediate early genes

PI-3 kinase/Atk pathway

-provides mitogenic signal


-promotes cell growth and cell survival

checkpoints

-provides moment for the cell cycle to be arrested if conditions are not appropriate


-arrest can be temporary (until problem is fixed) or permanent (G1 arrest)


-in extreme cases, damage induces apoptosis


-START: are mitogens present; is cell big enough; is DNA intact?


-G2/M: is DNA replication complete? is DNA intact?


-metaphase-to-anaphase: is spindle assembly complete? are all chromosomes attached to spindle?

role of p53

-guardian of the genome


-transcription factor that promotes transcription of cell cycle inhibitors and regulators of apoptosis


-in undamaged cells p53 associates with a ubiquitin ligase Mdm2, so is short-lived


-in stressed cells, p53 is phosphorylated, tetramerized, and actively promotes transcription of all those bad things

difference between proliferation and cell growth

-proliferation: regulated by mitogens


-cell growth: regulated by growth factors (which mostly regulate rate of protein synthesis and degredation (e.g. TOR pathway)

cancer is the result of...

accumulated genetic mutations and selection for growth and survival

oncogene

-genes that promote cell growth, division, and survival


-are dominant because their abnormally high level causes phenotype


-e.g. Ras

tumor suppressor

-genes that regulate and inhibit cell cycle


-are recessive because they need to lose function from both alleles in order to have a seen effect


-e.g. Rb

two ways to lose normal growth control

-overactivity of pathways that stimulate proliferation and survival (accelerator is stuck). caused by mutation or amplification of oncogenes


-inactivation of pathways that normally act to inhibit cell proliferation or induce cell death (breaks don't work). caused by mutation/deletion of tumor suppressor genes

how tumors overcome cellular defense mechanisms

-force the cell into cell cycle


-subvert normal checkpoint responses


-avoid senescence

mitogens

-can be peptide or lipid


-encourages cell division (mitosis)

DNA damage response

-blocks cell cycle when DNA is damaged


-kinases recruited to sites of DNA damage and activated


-leads to either production of DNA repair enzymes, reversible cell-cycle arrest, or permanent cell-cycle arrest or cell death

hyper-proliferative response

-cell cycle will not proliferate when something is "not right" (discordant or excess signaling)


-leads to ARF (Mdm2 inhibitor) allowing p53 to do its thing

TOR pathway

-activated by G protein Rheb


-leads to increased ribosome production and protein synthesis